# Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I)

> **NCT00106587** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital, Saarland** · enrollment: 52 (actual)

## Conditions studied

- Coronary Restenosis

## Interventions

- **DEVICE:** PTCA
- **COMBINATION_PRODUCT:** paclitaxel coated balloon catheter (device with drug)

## Key facts

- **NCT ID:** NCT00106587
- **Lead sponsor:** University Hospital, Saarland
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2006-11
- **Final completion:** 2012-03
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106587, "Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00106587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*